Journal of Applied Physiology Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 89: 176-181, 2000;
8750-7587/00 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (29)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Greiwe, J. S.
Right arrow Articles by Semenkovich, C. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Greiwe, J. S.
Right arrow Articles by Semenkovich, C. F.
Vol. 89, Issue 1, 176-181, July 2000

Exercise induces lipoprotein lipase and GLUT-4 protein in muscle independent of adrenergic-receptor signaling

Jeffrey S. Greiwe, John O. Holloszy, and Clay F. Semenkovich

Departments of Medicine and of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri 63110


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Exercise increases the expression of lipoprotein lipase (LPL) and GLUT-4 in skeletal muscle. Intense exercise increases catecholamines, and catecholamines without exercise can affect the expression of both LPL and GLUT-4. To test the hypothesis that adrenergic-receptor signaling is central to the induction of LPL and GLUT-4 by exercise, six untrained individuals [age 28 ± 4 (SD) yr, peak oxygen uptake 3.6 ± 0.3 l/min] performed two exercise bouts within 12 days. Exercise consisted of cycling at ~65% peak oxygen uptake for 60 min with (block trial) and without (control trial) adrenergic-receptor blockade. Exercise intensity was the same during the block and control trials. Plasma catecholamine concentrations were significantly higher and heart rates were significantly lower during the block trial compared with the control trial, consistent with known effects of adrenergic-receptor blockade. However, blockade did not prevent the induction of either LPL or GLUT-4 proteins assayed in biopsies of skeletal muscle. LPL was significantly increased by 170-240% and GLUT-4 was significantly increased by 32-51% at 22 h after exercise compared with before exercise during both the control and block trials. These findings provide evidence that exercise increases muscle LPL and GLUT-4 protein content via signals generated by alterations in cellular homeostasis and not by adrenergic-receptor stimulation.

catecholamines; lipid metabolism; glucose transport; beta -blocker; alpha -blocker


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

CARBOHYDRATES AND FATTY ACIDS are the main fuel sources utilized during exercise and during recovery from exercise. Lipoprotein lipase (LPL), the rate-limiting factor for the metabolism of triglyceride-rich lipoproteins, and GLUT-4, the major glucose transporter of skeletal muscle, are critical for the acquisition of fatty acids and glucose during and after exercise. The uptake of substrates after exercise replenishes energy stores in preparation for the next bout of exercise and provides fuel for muscle repair and other recovery functions (15).

Exercise depletes high-energy phosphates in muscle and increases the concentration of AMP, causing activation of AMP-activated protein kinase (AMPK). Activation of AMPK probably mediates translocation of GLUT-4 into the sarcolemma with exercise (9, 20). Exercise also increases mRNA and protein levels of both GLUT-4 and LPL in skeletal muscle within 18 h after a bout of exercise (29, 31, 32). The signaling events leading to enhanced expression (probably by activation of transcription) of the GLUT-4 and LPL genes have not yet been identified. Catecholamines increase as a function of exercise intensity (6) and interact with G protein-coupled cell-surface receptors. Both catecholamines and exercise are known to increase intracellular concentrations of cAMP, a signaling molecule implicated in the expression of LPL in skeletal and cardiac muscle (3-5, 27).

Although catecholamines stimulate LPL expression in resting muscle (3-5, 27), it is unclear whether the striking rise in catecholamines seen with exercise contributes to exercise induction of LPL. It is also not known whether catecholamines increase GLUT-4 expression. In this paper, we specifically address the question of whether the increase in skeletal muscle LPL and GLUT-4 protein after exercise is caused by adrenergic-receptor stimulation during exercise. To answer this question, we measured skeletal muscle LPL and GLUT-4 protein content after a single bout of exercise performed in the presence and absence of adrenergic-receptor blockade.


    METHODS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Subjects. Subjects were healthy, active, but untrained individuals who regularly performed recreational physical activities. Body composition was estimated from hydrostatic weight. The study was approved by the Washington University Human Studies Committee. Informed consent was obtained from each subject.

Oxygen uptake. A continuous cycle ergometer test was performed by each individual to determine peak oxygen uptake (VO2 peak). The protocol consisted of cycling at 100, 150, and 200 W for 3 min per exercise intensity, followed by 25 W increments every 1 min until exhaustion. An automated on-line system was used to collect and analyze expired air throughout the exercise test (Max-1, Physio-Dyne Instrument, Farmingdale, NY). Each subject met at least two of the following criteria during the VO2 peak protocol: plateau in oxygen consumption with increasing work rate, heart rate within 10 beats/min of age-predicted maximal heart rate, and a respiratory exchange ratio exceeding 1.11.

Exercise trials. Two exercise trials, one with and one without adrenergic-receptor blockade, were completed within a 7- to 12-day period. The order of the trials was randomized. Subjects did not exercise the day before each trial.

Adrenergic-receptor blockade was achieved with the nonselective alpha -blocker phenoxybenzamine (Dibenzyline, SmithKline Beecham Pharmaceuticals) and the nonselective beta -blocker propranolol (Inderal, Ayerst Laboratories). Phenoxybenzamine is an oral medication. It was not possible to obtain phentolamine, an intravenous alpha -blocker, for this study. At the time of these experiments, phentolamine use in the United States was limited to medical emergencies because of manufacturing problems. As previously described (36), alpha -blockade with phenoxybenzamine was started 3 days before the exercise trial at a dose of 10 mg by mouth four times per day (day 1). The dosage was progressively increased to 20 mg four times per day (day 2) and to 30 mg four times per day (day 3), and then subjects ingested 40 mg 1.5 h before the exercise bout on day 4. For beta -blockade (24), subjects received a primed (143 µg/kg) continuous intravenous infusion of propranolol, beginning 30 min before the exercise bout. At the start of exercise, the dosage was decreased to 1.4 µg · kg-1 · min-1, and infusion of propranolol was continued at this rate until 15 min after the completion of exercise.

On each exercise day, a blood sample was obtained in the morning after a 12-h fast. A vastus lateralis muscle biopsy was performed. Forty-five minutes later, subjects exercised for 1 h on an electrically braked cycle ergometer at ~65% VO2 peak. Oxygen uptake was measured at 15 min-intervals during the exercise bout, and power output was adjusted to maintain ~65% VO2 peak. After the exercise bout, subjects rested in bed for the next 22 h in the Washington University General Clinical Research Center. Blood samples were obtained periodically from an indwelling catheter, and muscle biopsies were performed 8 and 22 h after exercise. Diets during the protocol were standardized and identical for the two trials.

Muscle biopsies. Biopsies were performed as previously described (31). After the initial biopsy, the contralateral leg was used for the second biopsy. The third biopsy was performed 3 cm distal to the site of the initial biopsy. The biopsies for the second trial were performed in the same sequence as the first trial at sites 3 cm distal to the initial biopsies. Muscle samples were immediately cleansed with saline, trimmed of any visible fat, blotted dry, and frozen in liquid nitrogen. Samples were then stored at -80°C for subsequent analysis. Muscle samples from all time points were analyzed for LPL and GLUT-4 protein content by Western blotting as described previously (30, 31). Antibody-bound protein was visualized by using enhanced chemiluminescence (Amersham/Pharmacia Biotech). Protein bands were quantified by densitometry. Data are expressed per protein content. As shown previously (32), acute exercise has no detectable effect on the control protein myosin when this assay is used.

Blood sampling and analysis. A polyethylene catheter was inserted into an antecubital vein in the morning before the initial biopsy and kept patent with saline. Blood samples were obtained from the subjects before the initial biopsy, immediately before exercise, at 30 min of exercise, and just before completion of exercise. In addition, blood samples were obtained every 30 min for the first 2.5 h after exercise and then every 1 h for the next 6 h. Samples were subjected to centrifugation (15 min at 2,000 g), and the supernatant was collected and stored at -80°C until subsequent analyses. Samples were analyzed for insulin (25), catecholamines (33), leptin (23), glucose (Sigma Chemical, St. Louis, MO), and nonesterified fatty acids (Waco Chemicals, Dallas TX). Lipid and lipoprotein levels were measured after a 12-h fast in accordance with the Centers for Disease Control lipid standardization program.

Statistics. Muscle protein content of LPL and GLUT-4 as well as plasma samples were analyzed by using two-way repeated-measures analysis of variance. A Tukey post hoc test was performed when the analysis of variance revealed significant differences.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Subject characteristics are shown in Table 1. Exercise intensities during the two trials were not significantly different (Table 2). Heart rates were significantly lower during exercise for the block trial compared with the control trial (Table 2). Plasma epinephrine (Fig. 1A) and norepinephrine (Fig. 1B) concentrations were significantly higher during exercise for the block trial compared with the control trial, an expected result because receptor blockade interferes with normal catecholamine clearance. Lower heart rates and higher catecholamine levels during the block trial indicate that adrenergic-receptor blockade was successful.

                              
View this table:
[in this window]
[in a new window]
 
Table 1.   Subject characteristics


                              
View this table:
[in this window]
[in a new window]
 
Table 2.   Work and heart rate data for each exercise trial



View larger version (18K):
[in this window]
[in a new window]
 
Fig. 1.   Plasma epinephrine (A) and norepinephrine (B) concentrations during exercise bouts for control and block (adrenergic-receptor blockade by using phenoxybenzamine and propranolol) trials. A resting sample was obtained (-1 h), and then the subjects exercised for 60 min at ~65% peak oxygen uptake (0-1 h). After exercise, subjects rested in bed for 22 h. Blood samples were obtained at 30-min intervals for 3.5 h (1-4.5 h) after exercise and then every 60 min for an additional 5 h (4.5-9.5 h). A sample was also obtained at 22 h postexercise. Plasma levels were analyzed between control and block trial with a 2-way repeated-measures analysis of variance. A significant interaction was found between control and block trials (P < 0.01).

Muscle LPL protein content. Skeletal muscle biopsies were performed before and at 8 and 22 h after the exercise bout for both trials. Muscle was assayed for LPL and GLUT-4 protein content. The absolute amounts of muscle tissue LPL and GLUT-4 were variable between individuals. Therefore, LPL and GLUT-4 signals for each individual were compared with signals in the preexercise sample for each trial, and data were analyzed by repeated-measures analysis of variance to focus on differences associated with the intervention rather than differences between individuals. As shown in Fig. 2, left, LPL protein in the control trial was increased 8 h after exercise in the control trial. At 22 h after exercise in the control trial, LPL protein was increased by 170 ± 100% (P < 0.05). The same pattern was seen in the block trial (Fig. 2, right). At 22 h postexercise, LPL protein content was 240 ± 110% greater than baseline (P < 0.05) even though exercise was performed in the setting of both alpha - and beta -blockade.


View larger version (32K):
[in this window]
[in a new window]
 
Fig. 2.   Skeletal muscle lipoprotein lipase (LPL) protein content before exercise (baseline) and at 8 h (post 8h) and 22 h (post 22h) after exercise for control and block (adrenergic-receptor blockade by using phenoxybenzamine and propranolol) trials. Samples were obtained from the vastus lateralis muscle and were analyzed for LPL protein by quantitative Western blotting. For each individual, signals at 8 and 22 h after exercise were compared with baseline samples and analyzed by repeated-measures analysis of variance. Because error bars reflect variances for the differences between 8- and 22-h samples and baseline, no baseline error bars are shown. Actual baseline densitometry data were 0.72 ± 0.29 arbitrary units for control trial and 0.42 ± 0.17 arbitrary units for block trial. Insets, representative blots for control trial (left) and the block trial (right). * Significant difference (P < 0.05) comparing baseline and 22-h postexercise samples for each trial.

Muscle GLUT-4 protein content. GLUT-4 protein content was also elevated after exercise bouts in both the control and block trials (Fig. 3). GLUT-4 protein content was already elevated 8 h after exercise in each trial. By 22 h postexercise, GLUT-4 protein content was increased by 51 ± 16% (P < 0.05) in the control trial and by 32 ± 6% (P < 0.05) in the block trial compared with baseline.


View larger version (28K):
[in this window]
[in a new window]
 
Fig. 3.   Skeletal muscle GLUT-4 protein content before exercise and at 8 h and 22 h after exercise for control and block (adrenergic-receptor blockade by using phenoxybenzamine and propranolol) trials. Samples were obtained from vastus lateralis muscle and were analyzed for GLUT-4 protein by quantitative Western blotting. For each individual, signals at 8 and 22 h after exercise were compared with baseline samples and analyzed by repeated-measures analysis of variance. Because error bars reflect variances for the differences between 8- and 22-h samples and baseline, no baseline error bars are shown. Actual baseline densitometry data were 1.89 ± 0.39 arbitrary units for control trial and 1.65 ± 0.34 arbitrary units for block trial. Insets, representative blots for control trial (left) and block trial (right). * Significant difference (P < 0.05) comparing baseline and 22-h postexercise samples for each trial.

For LPL and GLUT-4 in both trials, a significant time main effect was found by two-way repeated-measures analysis of variance. These results suggest that, at least under the conditions of this experiment, the time course of induction of these proteins in human skeletal muscle is similar and unaffected by adrenergic-receptor blockade.

Insulin and glucose affect LPL and GLUT-4 expression. Adrenergic-receptor blockade was associated with lower insulin levels at 0-h (P = 0.04), 0.5-h (P = 0.05), and 1-h (P = 0.02), time points just before and during exercise (Fig. 4A). However, there were no significant differences at other time points and no significant differences at any time points for glucose concentrations (Fig. 4B).


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 4.   Plasma insulin (A) and glucose (B) concentrations during control and block trials. * P<= 0.05 compared with control samples at the same time point.

Circulating nonesterified fatty acids tend to increase with exercise because catecholamines promote the activity of hormone-sensitive lipase in adipose tissue. There was a trend for fatty acids to be lower during exercise in the block trial (data not shown), but these differences were not significant. There was no difference in circulating leptin levels between the trials (data not shown).


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Our results confirm that a single bout of exercise increases skeletal muscle LPL protein content (32). Several previous studies have reported the induction of GLUT-4 protein after 7-10 days of endurance exercise (2, 7). A prolonged, single bout of exercise is known to increase skeletal muscle GLUT-4 expression in rats (29). To the best of our knowledge, the present results represent initial data showing that a single bout of exercise also increases GLUT-4 protein in the skeletal muscle of humans.

The present results also provide insight into the mechanisms underlying the induction of these two proteins that are critical for normal glucose and lipid metabolism. Catecholamines increase as a function of exercise intensity (6), and interact with G protein-coupled adrenergic cell-surface receptors to affect numerous metabolic pathways. Blocking adrenergic receptors by using phenoxybenzamine (a nonspecific alpha -blocker) and propranolol (a nonspecific beta -blocker) during exercise did not prevent the induction of LPL and GLUT-4 protein in human skeletal muscle. These results suggest that, even in the absence of stimulation by catecholamines, skeletal muscle can activate signaling pathways that produce a coordinated response to ensure fuel acquisition.

At least for LPL, several lines of evidence suggest that catecholamines are involved in the response to exercise. Catecholamines increase cAMP, cAMP levels are increased as a function of exercise or in response to elevated plasma catecholamine concentrations (17, 21), and a cAMP-response element is present in the human LPL promoter (16). Urinary excretion rates of catecholamines account for >80% of the variability in human skeletal muscle LPL activity (22). Infusion of either epinephrine or isoproterenol increases skeletal muscle LPL expression in humans and rodents (3, 4, 27). Catecholamines also increase LPL activity in rat cardiac muscle (5).

The present results suggest that signaling induced by the interaction between catecholamines and adrenergic receptors is not required for the exercise-induced increase in LPL protein content. A previous study in humans concluded that local contractile activity is responsible for increased LPL activity in muscle (14), but it did not preclude possible local effects of catecholamines released from nerves innervating exercising muscles. By using systemic adrenergic-receptor blockade, our data also show that catecholamines released locally as a consequence of contractile activity do not play a critical role in LPL induction. Taken together with a study in rats (8), available data indicate that muscle contraction itself induces LPL. The mediator of this effect is unknown, although cAMP is an attractive candidate. cAMP levels are elevated during exercise even with beta -blockade (17, 18).

Studies of the effects of catecholamines on GLUT-4 are less consistent. Short-term infusion of epinephrine in rats after surgical removal of the adrenal medulla decreases GLUT-4 transcription (13), suggesting that catecholamines decrease GLUT-4 expression. Rats subjected to beta -blockade during 6 wk of exercise training show no increase in muscle GLUT-4, suggesting that catecholamines are necessary for the exercise-induced increase in GLUT-4 (19). The present results do not support this interpretation. One possible explanation for this apparent discrepancy is the fact that the rat study measured GLUT-4 >= 48 h after exercise, a time point at which adaptive changes in GLUT-4 would be reversed (12).

LPL protein content usually reflects LPL enzyme activity in skeletal muscle (31, 35). Under most circumstances, GLUT-4 protein content reflects the capacity of skeletal muscle to carry out glucose transport (10, 29, 30). Protein levels for LPL and GLUT-4 in the present study are probably elevated because of increased message levels. Previous studies by our laboratory using humans show that an increase in skeletal muscle LPL mRNA precedes an increase in LPL protein after exercise (32). Previous studies by our laboratory using rodents show that exercise induces GLUT-4 mRNA and protein (29). Others have demonstrated an increase in GLUT-4 transcription with exercise (26). Therefore, it is likely that exercise activates a transcriptional signaling pathway independent of adrenergic receptors to increase LPL and GLUT-4 protein. A critical issue is the nature of the signaling pathways that modulate activation of transcription by exercise.

AMPK, activated by energy depletion in muscle, is likely to be involved in the induction of exercise-responsive genes. Growing evidence implicates this kinase in GLUT-4 translocation (9, 20), and recent data indicate that AMPK induces GLUT-4 and hexokinase expression (11). However, the downstream mediators of AMPK are unknown. The mitogen-activated protein kinase pathway may be involved. Muscle contraction is a potent activator of this pathway (1). Mitogen-activated protein kinase may be responsible for the increased transcription of immediate-early genes in skeletal muscle after exercise (34).

Insulin-receptor signaling may also be involved in exercise responses. Skeletal muscle contraction has striking metabolic effects in the absence of insulin (28). Consistent with this notion, exercise increases skeletal muscle glucose transport in muscle-specific insulin-receptor knockout mice (37). However, insulin potentiates the exercise effect in these mice without skeletal muscle insulin receptors, suggesting that perhaps insulin receptors in nonmyocytes or insulin interacting with other receptors can affect exercise responses. In the present study, adrenergic-receptor blockade was associated with lower plasma insulin levels during exercise (Fig. 4A). Adrenergic-receptor signaling has complex effects on insulin secretion and action (38). Because lower insulin levels were seen without differences in plasma glucose (Fig. 4B), adrenergic-receptor blockade may modestly enhance insulin signaling during exercise, at least under the conditions of this experiment.

In summary, a single bout of exercise increases human skeletal muscle LPL and GLUT-4 protein content in the setting of both alpha - and beta -adrenergic-receptor blockade. Muscle contraction itself, perhaps acting in response to depletion of high-energy phosphate stores, appears to mediate fuel acquisition by muscle.


    ACKNOWLEDGEMENTS

We appreciate the commitment of our study subjects.


    FOOTNOTES

This work was supported by National Institute of Health (NIH) Grants AG-14658, HL-58427, and DK-53198; by the Washington University General Clinical Research Center (MO1 RR-00036); and by the Washington University Diabetes Research and Training Center (DK-20579). J. S. Greiwe was supported by NIH Institutional National Research Service Award AG-0078.

Address for reprint requests and other correspondence: C. F. Semenkovich, Washington Univ. School of Medicine, 660 S. Euclid Ave., Box 8046, St. Louis, MO 63110 (E-mail semenkov{at}im.wustl.edu).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.

Received 11 February 2000; accepted in final form 23 March 2000.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

1.   Aronson, D, Violan MA, Dufresne SD, Zangen D, Fielding RA, and Goodyear LJ. Exercise stimulates the mitogen-activated protein kinase pathway in human skeletal muscle. J Clin Invest 99: 1251-1257, 1997[Web of Science][Medline].

2.   Cox, JH, Cortright RN, Dohm GL, and Houmard JA. Effect of aging on response to exercise training in humans: skeletal muscle GLUT-4 and insulin sensitivity. J Appl Physiol 86: 2019-2025, 1999[Abstract/Free Full Text].

3.   Deshaies, Y, Geloen A, Paulin A, Marette A, and Bukowiecki LJ. Tissue-specific alterations in lipoprotein lipase activity in the rat after chronic infusion of isoproterenol. Horm Metab Res 25: 13-16, 1993[Web of Science][Medline].

4.   Eckel, RH, Jensen DR, Schlaepfer IR, and Yost TJ. Tissue-specific regulation of lipoprotein lipase by isoproterenol in normal-weight humans. Am J Physiol Regulatory Integrative Comp Physiol 271: R1280-R1286, 1996[Abstract/Free Full Text].

5.   Friedman, G, Chajek-Shaul T, Stein O, Noe L, Etienne J, and Stein Y. beta -Adrenergic stimulation enhances translocation, processing and synthesis of lipoprotein lipase in rat heart cells. Biochim Biophys Acta 877: 112-120, 1986[Medline].

6.   Greiwe, JS, Hickner RC, Shah SD, Cryer PE, and Holloszy JO. Norepinephrine response to exercise at the same relative intensity before and after endurance exercise training. J Appl Physiol 86: 531-535, 1999[Abstract/Free Full Text].

7.   Gulve, EA, and Spina RJ. Effects of 7-10 days of cycle ergometer exercise on skeletal muscle GLUT-4 protein content. J Appl Physiol 79: 1562-1566, 1995[Abstract/Free Full Text].

8.   Hamilton, MT, Etienne J, McClure WC, Pavey BS, and Holloway AK. Role of local contractile activity and muscle fiber type on LPL regulation during exercise. Am J Physiol Endocrinol Metab 275: E1016-E1022, 1998[Abstract/Free Full Text].

9.   Hayashi, T, Hirshman MF, Kurth EJ, Winder WW, and Goodyear LJ. Evidence for 5' AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport. Diabetes 47: 1369-1373, 1998[Abstract].

10.   Holloszy, JO, and Hansen PA. Regulation of glucose transport into skeletal muscle. Rev Physiol Biochem Pharmacol 128: 99-193, 1996[Web of Science][Medline].

11.   Holmes, BF, Kurth-Kraczek EJ, and Winder WW. Chronic activation of 5'-AMP-activated protein kinase increases GLUT-4, hexokinase, and glycogen in muscle. J Appl Physiol 87: 1990-1995, 1999[Abstract/Free Full Text].

12.   Host, HH, Hansen PA, Nolte LA, Chen MM, and Holloszy JO. Rapid reversal of adaptive increases in muscle GLUT-4 and glucose transport capacity after training cessation. J Appl Physiol 84: 798-802, 1998[Abstract/Free Full Text].

13.   Jones, JP, and Dohm GL. Regulation of glucose transporter GLUT-4 and hexokinase II gene transcription by insulin and epinephrine. Am J Physiol Endocrinol Metab 273: E682-E687, 1997[Abstract/Free Full Text].

14.   Kiens, B, Lithell H, Mikines KJ, and Richter EA. Effects of insulin and exercise on muscle lipoprotein lipase activity in man and its relation to insulin action. J Clin Invest 84: 1124-1129, 1989.

15.   Kiens, B, and Richter EA. Utilization of skeletal muscle triacylglycerol during postexercise recovery in humans. Am J Physiol Endocrinol Metab 275: E332-E337, 1998[Abstract/Free Full Text].

16.   Kirchgessner, TG, Chuat J-C, Heinzmann C, Etienne J, Guilhot S, Svenson K, Ameis D, Pilon C, D'Auriol L, Andalibi A, Schotz MC, Galibert F, and Lusis AJ. Organization of the human lipoprotein lipase gene and evolution of the lipase gene family. Proc Natl Acad Sci USA 86: 9647-9651, 1989[Abstract/Free Full Text].

17.   Kraus, WE, Bernard TS, and Williams RS. Interactions between sustained contractile activity and beta -adrenergic receptors in regulation of gene expression in skeletal muscles. Am J Physiol Cell Physiol 256: C506-C514, 1989[Abstract/Free Full Text].

18.   Kraus, WE, Longabaugh JP, and Liggett SB. Electrical pacing induces adenylyl cyclase in skeletal muscle independent of the beta -adrenergic receptor. Am J Physiol Endocrinol Metab 263: E226-E230, 1992[Abstract/Free Full Text].

19.   Kuo, C-H, Ding Z, and Ivy JL. Interaction of exercise training and clenbuterol on GLUT-4 protein in muscle of obese Zucker rats. Am J Physiol Endocrinol Metab 271: E847-E854, 1996[Abstract/Free Full Text].

20.   Kurth-Kraczek, EJ, Hirshman MF, Goodyear LJ, and Winder WW. 5' AMP-activated protein kinase activation causes GLUT-4 translocation in skeletal muscle. Diabetes 48: 1667-1671, 1998[Abstract].

21.   Lee, AD, Hansen PA, Schluter J, Gulve EA, Gao J, and Holloszy JO. Effects of epinephrine on insulin-stimulated glucose uptake and GLUT-4 phosphorylation in muscle. Am J Physiol Cell Physiol 273: C1082-C1087, 1997[Abstract/Free Full Text].

22.   Lithell, H, Cedermark M, Fröberg J, Tesch P, and Karlsson J. Increase of lipoprotein lipase activity in skeletal muscle during heavy exercise. Relation to epinephrine excretion. Metabolism 30: 1130-1134, 1981[Web of Science][Medline].

23.   Ma, Z, Gingerich RL, Santiago JV, Klein S, Smith CH, and Landt M. Analysis of human plasma leptin by radioimmunoassay. Clin Chem 42: 942-946, 1996[Abstract/Free Full Text].

24.   Marker, JC, Hirsch IB, Smith LJ, Parvin CA, Holloszy JO, and Cryer PE. Catecholamines in prevention of hypoglycemia during exercise in humans. Am J Physiol Endocrinol Metab 260: E705-E712, 1991[Abstract/Free Full Text].

25.   Morgan, DR, and Lazarow A. Immunoassay of insulin: two antibody system. Diabetes 12: 115-126, 1963[Web of Science].

26.   Neufer, PD, and Dohm GL. Exercise induces a transient increase in transcription of the GLUT-4 gene in skeletal muscle. Am J Physiol Cell Physiol 265: C1597-C1603, 1993[Abstract/Free Full Text].

27.   Pedersen, SB, Bak JF, Holck P, Schmitz O, and Richelsen B. Epinephrine stimulates human muscle lipoprotein lipase activity in vivo. Metabolism 48: 461-464, 1999[Web of Science][Medline].

28.   Ploug, T, Galbo H, and Richter EA. Increased muscle glucose uptake during contractions: no need for insulin. Am J Physiol Endocrinol Metab 247: E726-E731, 1984[Abstract/Free Full Text].

29.   Ren, JM, Semenkovich CF, Gulve EA, Gao J, and Holloszy JO. Exercise induces rapid increases in GLUT-4 expression, transport capacity, and insulin-stimulated glycogen storage in muscle. J Biol Chem 269: 14396-14401, 1994[Abstract/Free Full Text].

30.   Ren, JM, Semenkovich CF, and Holloszy JO. Adaptation of muscle to creatine depletion: effect on GLUT-4 glucose transporter expression. Am J Physiol Cell Physiol 264: C146-C150, 1993[Abstract/Free Full Text].

31.   Seip, RL, Angelopoulos TJ, and Semenkovich CF. Exercise induces human lipoprotein lipase gene expression in skeletal muscle but not adipose tissue. Am J Physiol Endocrinol Metab 268: E229-E236, 1995[Abstract/Free Full Text].

32.   Seip, RL, Mair K, Cole TG, and Semenkovich CF. Induction of human skeletal muscle lipoprotein lipase gene expression by short-term exercise is transient. Am J Physiol Endocrinol Metab 272: E255-E261, 1997[Abstract/Free Full Text].

33.   Shah, SD, Clutter WE, and Cryer PE. External and internal standards in the single isotope derivative (radioenzymatic) assay of plasma norepinephrine and epinephrine in normal humans and persons with diabetes mellitus or chronic renal failure. J Lab Clin Med 106: 624-629, 1985[Web of Science][Medline].

34.   Sherwood, DJ, Dufresne SD, Markuns JF, Cheatham B, Moller DE, Aronson D, and Goodyear LJ. Differential regulation of MAP kinase, p70S6K, and Akt by contraction and insulin in rat skeletal muscle. Am J Physiol Endocrinol Metab 276: E870-E878, 1999[Abstract/Free Full Text].

35.   Simsolo, RB, Ong JM, and Kern PA. The regulation of adipose tissue and muscle lipoprotein lipase in runners by detraining. J Clin Invest 92: 2124-2130, 1993.

36.   Sundin, T, Dahlstrom A, Norlen L, and Svedmyr N. The sympathetic innervation and adrenoreceptor function of the human lower urinary tract in the normal state and after parasympathetic denervation. Invest Urol 14: 322-328, 1977[Web of Science][Medline].

37.   Wojtaszewski, JFP, Higaki Y, Hirshman MF, Michael MD, Dufresne SD, Kahn CR, and Goodyear LJ. Exercise modulates postreceptor insulin signaling and glucose transport in muscle-specific insulin receptor knockout mice. J Clin Invest 104: 1257-1264, 1999[Web of Science][Medline].

38.   Young, JB, and Landsberg L. Catecholamines and the adrenal medulla. In: Williams Textbook of Endocrinology (9th ed.). Philadelphia, PA: Saunders, 1998, p. 665-728.


J APPL PHYSIOL 89(1):176-181
8570-7587/00 $5.00 Copyright © 2000 the American Physiological Society



This article has been cited by other articles:


Home page
ptjournalHome page
L. P Turcotte and J. S Fisher
Skeletal Muscle Insulin Resistance: Roles of Fatty Acid Metabolism and Exercise
Physical Therapy, November 1, 2008; 88(11): 1279 - 1296.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
H. J. Green, T. A. Duhamel, G. P. Holloway, J. W. Moule, D. W. Ranney, A. R. Tupling, and J. Ouyang
Rapid upregulation of GLUT-4 and MCT-4 expression during 16 h of heavy intermittent cycle exercise
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2008; 294(2): R594 - R600.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J. Q. Zhang, L. L. Ji, D. L. Fogt, and V. S. Fretwell
Effect of exercise duration on postprandial hypertriglyceridemia in men with metabolic syndrome
J Appl Physiol, October 1, 2007; 103(4): 1339 - 1345.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
L. Fontana, D. T. Villareal, E. P. Weiss, S. B. Racette, K. Steger-May, S. Klein, J. O. Holloszy, and and the Washington University School of Medicine C
Calorie restriction or exercise: effects on coronary heart disease risk factors. A randomized, controlled trial
Am J Physiol Endocrinol Metab, July 1, 2007; 293(1): E197 - E202.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
K. A. Burgomaster, N. M. Cermak, S. M. Phillips, C. R. Benton, A. Bonen, and M. J. Gibala
Divergent response of metabolite transport proteins in human skeletal muscle after sprint interval training and detraining
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2007; 292(5): R1970 - R1976.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
G. N. Kraniou, D. Cameron-Smith, and M. Hargreaves
Acute exercise and GLUT4 expression in human skeletal muscle: influence of exercise intensity
J Appl Physiol, September 1, 2006; 101(3): 934 - 937.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
F. Magkos, D. C. Wright, B. W. Patterson, B. S. Mohammed, and B. Mittendorfer
Lipid metabolism response to a single, prolonged bout of endurance exercise in healthy young men
Am J Physiol Endocrinol Metab, February 1, 2006; 290(2): E355 - E362.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
G. N. Kraniou, D. Cameron-Smith, and M. Hargreaves
Effect of short-term training on GLUT-4 mRNA and protein expression in human skeletal muscle
Exp Physiol, September 1, 2004; 89(5): 559 - 563.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. L. McGee and M. Hargreaves
Exercise and Myocyte Enhancer Factor 2 Regulation in Human Skeletal Muscle
Diabetes, May 1, 2004; 53(5): 1208 - 1214.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. O. Holloszy
A forty-year memoir of research on the regulation of glucose transport into muscle
Am J Physiol Endocrinol Metab, March 1, 2003; 284(3): E453 - E467.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. Q. Zhang, B. Smith, M. M. Langdon, H. L. Messimer, G. Y. Sun, R. H. Cox, M. James-Kracke, and T. R. Thomas
Changes in LPLa and reverse cholesterol transport variables during 24-h postexercise period
Am J Physiol Endocrinol Metab, August 1, 2002; 283(2): E267 - E274.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
F. W. Booth, M. V. Chakravarthy, S. E. Gordon, and E. E. Spangenburg
Waging war on physical inactivity: using modern molecular ammunition against an ancient enemy
J Appl Physiol, July 1, 2002; 93(1): 3 - 30.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
A. Steensberg, G. van Hall, C. Keller, T. Osada, P. Schjerling, B. Klarlund Pedersen, B. Saltin, and M. A Febbraio
Muscle glycogen content and glucose uptake during exercise in humans: influence of prior exercise and dietary manipulation
J. Physiol., May 15, 2002; 541(1): 273 - 281.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. H. Goodpaster, J. He, S. Watkins, and D. E. Kelley
Skeletal Muscle Lipid Content and Insulin Resistance: Evidence for a Paradox in Endurance-Trained Athletes
J. Clin. Endocrinol. Metab., December 1, 2001; 86(12): 5755 - 5761.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. S. Greiwe, G. Kwon, M. L. McDaniel, and C. F. Semenkovich
Leucine and insulin activate p70 S6 kinase through different pathways in human skeletal muscle
Am J Physiol Endocrinol Metab, September 1, 2001; 281(3): E466 - E471.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
G. D. Wadley, R. J. Tunstall, A. Sanigorski, G. R. Collier, M. Hargreaves, and D. Cameron-Smith
Differential effects of exercise on insulin-signaling gene expression in human skeletal muscle
J Appl Physiol, February 1, 2001; 90(2): 436 - 440.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
P. Schjerling, M. Hargreaves, D. Cameron-Smith, and Y. Kraniou
The Importance of Internal Controls in mRNA Quantification
J Appl Physiol, January 1, 2001; 90(1): 401 - 402.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (29)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Greiwe, J. S.
Right arrow Articles by Semenkovich, C. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Greiwe, J. S.
Right arrow Articles by Semenkovich, C. F.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online